PKC412 in Patients With Acute Myeloid Leukemia and Patients With Myelodysplastic Syndrome With Either Wild Type or Mutated FLT3

This study has been completed.

Study NCT00045942 Information provided by Novartis

First Received: September 16, 2002 Last Updated: November 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	February 2006
Primary Completion Date:	September 2003 (Final data collection date for primary outcome measure)